{{ infobox person
| name = 白理惟<br>Dr. Olivier Brandicourt
| image = Olivier Brandicourt.jpg
| honorific_suffix = 医学博士
| birth_date = {{birth date and age|1956|2|13|df=yes}}
| birth_place = {{MAR}}[[卡萨布兰卡|卡萨布兰卡]]
| nationality = {{FRA}}
| occupation = [[赛诺菲|赛诺菲]]CEO
}}

'''白理惟''' （{{lang-fr|Olivier Brandicourt}}, {{bd|1956年|2月13日||}}）是一位法国企业家和医学家，目前担任[[赛诺菲|赛诺菲]]CEO。中文名叫'''白理惟'''。

==生平==
毕业于[[巴黎第五大学|巴黎第五大学]]细胞和免疫病理生理学硕士专业和[[巴黎第十二大学|巴黎第十二大学]]生物学硕士专业，又在[[刚果共和国|刚果共和国]]行医两年。<ref name="wsjnoemie" />之后在巴黎[[Pitié-SalpêtrièreHospital|Pitié-SalpêtrièreHospital]]攻读医学八年，研究传染疾病和热带医药，以及西非和中非的疟疾研究。<ref>{{Cite web|url=http://en.sanofi.com/investors/corporate_governance/corporate_management/bio-brandicourt.aspx|title=Bio on www.sanofi.com|last=|first=|date=|website=www.sanofi.com|archive-url=https://web.archive.org/web/20150407084544/http://en.sanofi.com/investors/corporate_governance/corporate_management/bio-brandicourt.aspx|archive-date=2015年4月7日|dead-url=yes|access-date=|df=|accessdate=2017年8月10日|archiveurl=https://web.archive.org/web/20150407084544/http://en.sanofi.com/investors/corporate_governance/corporate_management/bio-brandicourt.aspx|archivedate=2015年4月7日|deadurl=yes}}</ref>2000年加入[[辉瑞|辉瑞]]，最终做到初级保健事业部经理。<ref>{{Cite web|url=http://www.businesswire.com/news/home/20120523005767/en/Pfizer-Names-Olivier-Brandicourt-President-General-Manager|title=Press release - May 23, 2012|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref><ref>{{Cite web|url=http://www.pmlive.com/pharma_news/pfizer_olivier_brandicourt_president_emerging_markets_404867|title=Pfizer promotes Olivier Brandicourt to emerging markets president|last=|first=|date=|website=PMLive.com|archive-url=|archive-date=|dead-url=|access-date=}}</ref>。他曾担任[[辉瑞|辉瑞]]公司执行领导团队的成员，并负责引入胆固醇治疗立普妥。<ref name="wsjnoemie" /><ref name="Bloomberg">Bloomberg, [https://www.bloomberg.com/research/stocks/people/person.asp?personId=83197162&ticker=P Executive Profile], February 25, 2015</ref> 2007年他负责的胰岛素雾化吸入剂[[Exubera|Exubera]]的上市失败。<ref>{{cite web |url=http://www.nytimes.com/2007/04/10/business/10drug.html |title=Pfizer Drug for Diabetes Is Lagging |website=Nytimes.com |date=1 April 2007 |author=Alex Berenson  |access-date=23 April 2017}}</ref>2013年至2015年担任[[拜耳|拜耳]]医疗卫生公司CEO和董事会主席，主要负责领导该公司在全球的医疗保健产品，包括药品、消费者保健、动物保健和医疗保健业务。<ref name="healthcare">Bayer HealthCare, [http://healthcare.bayer.com/scripts/pages/en/company/corporate_profile/executive_committee/dr_olivier_brandicourt/index.php Executive Committee], February 25, 2015  {{webarchive|url=https://web.archive.org/web/20150225225602/http://healthcare.bayer.com/scripts/pages/en/company/corporate_profile/executive_committee/dr_olivier_brandicourt/index.php |date=2015年2月25日 }}</ref> 

2015年4月2日被任命为[[赛诺菲|赛诺菲]]CEO。<ref name="wsjnoemie">Noemie Bisserbe, [https://www.wsj.com/articles/sanofi-appoints-olivier-brandicourt-chief-executive-1424383378 Sanofi Names Olivier Brandicourt CEO], ''[[The_Wall_Street_Journal|The Wall Street Journal]]'', February 20, 2015</ref><ref name="ftandrewward">Andrew Ward, [http://www.ft.com/cms/s/0/8cb2611a-b900-11e4-b8e6-00144feab7de.html#axzz3SekS8nmf Five big challenges facing Sanofi’s new chief Olivier Brandicourt], ''Financial Times'', 15 February 2015</ref><ref>Andrew Ward, [http://www.ft.com/cms/s/0/beebfdce-b880-11e4-b6a5-00144feab7de.html#axzz3SekS8nmf Sanofi appoints Brandicourt as CEO], ''[[Financial_Times|Financial Times]]'', February 19, 2015</ref>2015年11月，[[赛诺菲|赛诺菲]]发布其2020年战略计划，包括结构重组为3个主要板块：糖尿病，心血管和疫苗。<ref>{{cite web |url=http://mediaroom.sanofi.com/sanofi-sets-out-strategic-roadmap-for-long-term-growth-2/ |title=Sanofi Sets Out Strategic Roadmap for Long-term Growth |website=Sanofi.com |date=6 November 2015 |access-date=23 April 2017}}</ref> 2016年5月，他宣布将公司管理层重新洗牌以适应其2020年战略计划。<ref>{{cite web |url=http://thefly.com/landingPageNews.php?id=2378839&headline=SNY-Sanofi-changes-executive-committee-aligned-to--strategic-roadmap |title=Sanofi changes executive committee aligned to 2020 strategic roadmap  |website=Thefly.com |date=23 May 2016 |access-date=23 April 2017}}</ref>

==争议==
他的[[解雇金|解雇金]]高达450万美元，受到法国农业部长[[Stéphane_Le_Foll|Stéphane Le Foll]]和法国环境和能源部长[[塞戈莱纳·罗亚尔|塞戈莱纳·罗亚尔]]的批评。<ref name="wsjgoldenhandshake">Ed Silverman, [https://blogs.wsj.com/pharmalot/2015/02/24/french-government-slams-sanofi-over-brandicourt-pay-package/ French Government Slams Sanofi Over Brandicourt Pay Package], ''The Wall Street Journal'', 24 February 2015</ref>

==参考来源==
{{Reflist}}

==外部链接==
[https://web.archive.org/web/20150407084544/http://en.sanofi.com/investors/corporate_governance/corporate_management/bio-brandicourt.aspx 赛诺菲官网]

{{start box}}
{{s-bus}}
{{succession box
| before = [[魏巴赫|魏巴赫]]
| title  = [[赛诺菲|赛诺菲]]CEO
| years  = 2015年4月2日–
| after  = 目前
}}
{{end box}}

{{DEFAULTSORT:Brandicourt, Olivier}}
[[Category:法国企业家|Category:法国企业家]]
[[Category:法国医学家|Category:法国医学家]]
[[Category:法国首席执行官|Category:法国首席执行官]]
[[Category:巴黎第五大学校友|Category:巴黎第五大学校友]]
[[Category:巴黎第十二大学校友|Category:巴黎第十二大学校友]]
[[Category:拜耳人物|Category:拜耳人物]]
[[Category:辉瑞人物|Category:辉瑞人物]]
[[Category:赛诺菲人物|Category:赛诺菲人物]]
[[Category:卡萨布兰卡人|Category:卡萨布兰卡人]]